NO156202C - Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonsyre-addisjonssalter av sultamicillin. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonsyre-addisjonssalter av sultamicillin.

Info

Publication number
NO156202C
NO156202C NO831430A NO831430A NO156202C NO 156202 C NO156202 C NO 156202C NO 831430 A NO831430 A NO 831430A NO 831430 A NO831430 A NO 831430A NO 156202 C NO156202 C NO 156202C
Authority
NO
Norway
Prior art keywords
sultamicillin
preparation
acid addition
addition salts
therapeutic active
Prior art date
Application number
NO831430A
Other languages
English (en)
Norwegian (no)
Other versions
NO156202B (no
NO831430L (no
Inventor
Wayne Ernest Barth
Vytautas John Jasys
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO831430L publication Critical patent/NO831430L/no
Publication of NO156202B publication Critical patent/NO156202B/no
Publication of NO156202C publication Critical patent/NO156202C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO831430A 1982-04-23 1983-04-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonsyre-addisjonssalter av sultamicillin. NO156202C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/371,156 US4432987A (en) 1982-04-23 1982-04-23 Crystalline benzenesulfonate salts of sultamicillin

Publications (3)

Publication Number Publication Date
NO831430L NO831430L (no) 1983-10-24
NO156202B NO156202B (no) 1987-05-04
NO156202C true NO156202C (no) 1987-08-19

Family

ID=23462725

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831430A NO156202C (no) 1982-04-23 1983-04-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonsyre-addisjonssalter av sultamicillin.

Country Status (27)

Country Link
US (1) US4432987A (ja)
EP (1) EP0092968B1 (ja)
JP (1) JPS58201792A (ja)
KR (1) KR860001279B1 (ja)
AU (1) AU536854B2 (ja)
CA (1) CA1187484A (ja)
CS (1) CS235320B2 (ja)
DD (1) DD209632A5 (ja)
DE (1) DE3362502D1 (ja)
DK (1) DK162168C (ja)
EG (1) EG16412A (ja)
ES (1) ES521728A0 (ja)
FI (1) FI76092C (ja)
GR (1) GR78582B (ja)
HK (1) HK20588A (ja)
HU (1) HU187068B (ja)
IE (1) IE54628B1 (ja)
IL (1) IL68453A (ja)
NO (1) NO156202C (ja)
NZ (1) NZ203988A (ja)
PH (1) PH18035A (ja)
PL (1) PL134978B1 (ja)
PT (1) PT76587B (ja)
SG (1) SG104087G (ja)
SU (1) SU1138030A3 (ja)
YU (1) YU43170B (ja)
ZA (1) ZA832845B (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
WO1987002893A1 (en) * 1985-11-18 1987-05-21 Board Of Regents, The University Of Texas System Polychelating agents for image and spectral enhancement (and spectral shift)
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
WO1995029913A1 (fr) * 1994-05-02 1995-11-09 Shionogi & Co., Ltd. Cristal de derive de pyrrolidylthiocarbapeneme, preparation lyophilisee le contenant et son procede de production
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
MXPA05002253A (es) 2002-08-29 2005-06-08 Taisho Pharma Co Ltd Sales bencenosulfonato de derivados de 4-fluoro-2-cianopirrolidina.
EP1606293B1 (en) * 2003-03-27 2009-08-19 Basilea Pharmaceutica AG Cephalosporin in crystalline form
EP1677758A1 (en) * 2003-10-31 2006-07-12 ALZA Corporation Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid
FR2877696B1 (fr) 2004-11-09 2009-09-18 Renault Sas Dispositif et procede d'estimation en temps reel de l'angle de debut de combustion d'un moteur a combustion interne
TW201446748A (zh) 2007-08-22 2014-12-16 Astrazeneca Ab 環丙基醯胺衍生物
JP5535925B2 (ja) 2007-10-26 2014-07-02 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア アンドロゲン受容体調節物質としてのジアリールヒダントイン化合物
EP4242206A1 (en) * 2009-01-30 2023-09-13 Novartis AG Crystalline n-{(1-s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
WO2011006061A1 (en) * 2009-07-10 2011-01-13 Evolva Sa Diyne compositions
EP2536701A4 (en) * 2010-02-18 2014-05-07 Astrazeneca Ab SOLID FORMS WITH A CYCLOPROPYLAMID DERIVATIVE
EP2536702A4 (en) * 2010-02-18 2013-07-10 Astrazeneca Ab NEW CRYSTALLINE FORM OF A CYCLOPROPYLBENZAMIDE DERIVATIVE
US9518004B2 (en) * 2012-12-03 2016-12-13 Kaneka Corporation Reduced coenzyme Q10 derivative and method for production thereof
US9643920B2 (en) * 2013-09-05 2017-05-09 Mitsubishi Tanabe Pharma Corporation Crystalline 4-(3S-(1R-(1-napthyl)ethylamino)pyrrolidin-1-yl)phenylacetic acid
AU2015335950B2 (en) * 2014-10-21 2018-01-25 Takeda Pharmaceutical Company Limited Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl}pyrimidine-2,4-diamine
CN104958318A (zh) * 2015-08-04 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗感染性疾病的药物舒巴坦钠组合物
CN108495844B (zh) * 2016-01-22 2022-12-02 桑多斯股份公司 结晶埃拉环素二盐酸盐
KR20230074840A (ko) * 2016-07-07 2023-05-31 사이클리온 테라퓨틱스, 인크. sGC 자극제의 고체 형태
WO2019089540A1 (en) * 2017-10-30 2019-05-09 Theracaine Llc Hydrophobic arenesulfonate salts
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
KR830001903B1 (ko) * 1979-02-13 1983-09-19 레오 파마슈티칼 프로덕츠 리미티드 페니실란산유도체의 제조방법
IE49880B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd Penicillin derivatives
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
GB2084572B (en) * 1980-10-06 1984-07-11 Leo Pharm Prod Ltd 1,1-dioxopenicillanoyloxymethyl 6-(d-aphenylacetamido)penicillanate napsylate
IL64009A (en) * 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CA1187484A (en) 1985-05-21
JPS58201792A (ja) 1983-11-24
NO156202B (no) 1987-05-04
KR840004437A (ko) 1984-10-15
FI76092C (fi) 1988-09-09
EP0092968B1 (en) 1986-03-12
US4432987A (en) 1984-02-21
DK101783A (da) 1983-10-24
DK101783D0 (da) 1983-02-28
IE54628B1 (en) 1989-12-20
HK20588A (en) 1988-03-25
DK162168B (da) 1991-09-23
FI76092B (fi) 1988-05-31
IE830926L (en) 1983-10-23
IL68453A0 (en) 1983-07-31
JPH0119395B2 (ja) 1989-04-11
IL68453A (en) 1986-08-31
PH18035A (en) 1985-03-06
AU1387183A (en) 1983-11-17
PL134978B1 (en) 1985-09-30
FI831392A0 (fi) 1983-04-22
PT76587A (en) 1983-05-01
DE3362502D1 (en) 1986-04-17
CS235320B2 (en) 1985-05-15
ES8406075A1 (es) 1984-07-01
EP0092968A1 (en) 1983-11-02
SU1138030A3 (ru) 1985-01-30
KR860001279B1 (ko) 1986-09-05
HU187068B (en) 1985-11-28
GR78582B (ja) 1984-09-27
DK162168C (da) 1992-03-02
DD209632A5 (de) 1984-05-16
NO831430L (no) 1983-10-24
NZ203988A (en) 1986-01-24
ES521728A0 (es) 1984-07-01
PT76587B (en) 1986-02-27
EG16412A (en) 1989-03-30
YU90483A (en) 1986-04-30
SG104087G (en) 1988-07-15
ZA832845B (en) 1984-11-28
PL241553A1 (en) 1983-11-21
YU43170B (en) 1989-04-30
FI831392L (fi) 1983-10-24
AU536854B2 (en) 1984-05-24

Similar Documents

Publication Publication Date Title
NO156202C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonsyre-addisjonssalter av sultamicillin.
NO871267D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO851949L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO151546C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoner
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO831610L (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxicamderivater.
NO163693C (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser av platina.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO162155C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylkarbonoksylsyrederivater.
NO162619C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive l-aminosyre-derivater
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO863373L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
NO164895C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO158579C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt n-(2-metoksyetyl)-noroksymorfon.
NO160001C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive spiro-3-hetero-azolon-derivater.

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN APRIL 2003